Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 41Unknown 14Terminated 14Withdrawn 9Active not recruiting 5Suspended 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Observational 14Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 2Plasma cell 1

Conditions

Breast Neoplasms 704Carcinoma, Non-Small-Cell Lung 470Prostatic Neoplasms 420Neoplasms 380Multiple Myeloma 264Colorectal Neoplasms 261Lung Neoplasms 247Neoplasm Metastasis 229Melanoma 215Ovarian Neoplasms 191Leukemia, Myeloid, Acute 189Pancreatic Neoplasms 182Squamous Cell Carcinoma of Head and Neck 163Recurrence 147Carcinoma, Renal Cell 145Lymphoma 142Glioblastoma 138Lymphoma, Non-Hodgkin 135Stomach Neoplasms 128Triple Negative Breast Neoplasms 127Brain Neoplasms 124Carcinoma, Hepatocellular 123Leukemia, Lymphocytic, Chronic, B-Cell 122Uterine Cervical Neoplasms 117Head and Neck Neoplasms 117Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Urinary Bladder Neoplasms 113Lymphoma, Large B-Cell, Diffuse 105Sarcoma 102Lymphoma, Follicular 100

Interventions

Standard of Care 3Practice Guidelines as Topic 2NVX-CoV2373 adjuvated lipid nanoparticle 1COVID-19 Vaccines 1COH04S1 COVID-19 vaccine 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × COVID-19 × Clear all
NCT04565665 2026-05-20

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
65 enrolled
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT05102656 2026-05-20

Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic

M.D. Anderson Cancer Center

Phase NA Active not recruiting
107 enrolled
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT04977024 2026-02-11

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

GeoVax, Inc.

Phase 2 Active not recruiting
63 enrolled
LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Multiple Myeloma

NCT03305341 2025-06-11

COVSP-BCG

Medicine Invention Design, Inc

Phase EARLY_PHASE1 Active not recruiting
20 enrolled

COVID-19

NCT04904536 2025-04-10

STRONGER

The George Institute

Phase 3 Active not recruiting
190 enrolled
Lymphoid

COVID-19, Lymphoma, Follicular, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡